A phase I study of imatinib, dacarbazine, and capecitabine in advanced endocrine cancers

BACKGROUND: Patients with advanced endocrine cancers, such as adrenocortical carcinoma and medullary thyroid carcinoma, have few well-validated therapeutic options. Pre-clinical studies have suggested potential activity of imatinib in these tumors. We therefore sought to establish a safe, novel trea...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Halperin, Daniel M, Phan, Alexandria T, Hoff, Ana O, Aaron, Marie, Yao, James C, Hoff, Paulo M
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2014
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4125701/
https://ncbi.nlm.nih.gov/pubmed/25086465
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-561
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk